Preferred Label : ALK Peptide Vaccine;
NCIt definition : A peptide cancer vaccine directed against the receptor tyrosine kinase anaplastic
lymphoma kinase (ALK), with potential immunostimulatory and antineoplastic activities.
Upon administration, ALK peptide vaccine may elicit a cytotoxic T-lymphocyte (CTL)
response against ALK-expressing tumor cells. ALK dysregulation and gene rearrangements
are associated with a variety of tumor cell types.;
Origin ID : C212143;
chemical_or_drug_has_mechanism_of_action
- concept_is_in_subset
- has_target
